☆ 4.5 Article

Design, synthesis, and biological evaluation of 4-(1H-1,2,3-triazol-1-yl)benzamides as HSP90 inhibitors

MOLECULAR DIVERSITY (2023)

Related references

Note: Only part of the references are listed.

Review Cell Biology

Quality control of the mitochondrial proteome

Jiyao Song et al.

Summary: Mitochondria contain a diverse array of proteins from two genomes and require synchronized gene expression for proper function. The mitochondrial proteome is highly adaptable and regulated by quality control systems to ensure cellular adaptation and functionality. Defects in mitochondrial protein quality control mechanisms can lead to proteotoxic insults and cell death, highlighting the critical importance of maintaining protein homeostasis in mitochondria.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)

Add to Collection

Article Chemistry, Applied

An HSP90 inhibitor based fluorescent probe for selective tumor targeting

Shulei Zhu et al.

Summary: A fluorescent probe based on an HSP90 inhibitor was synthesized in this study, showing potential for selective tumor targeting and early diagnosis.

DYES AND PIGMENTS (2021)

Add to Collection

Article Chemistry, Medicinal

Discovering High Potent Hsp90 Inhibitors as Antinasopharyngeal Carcinoma Agents through Fragment Assembling Approach

Mengyang Xu et al.

Summary: The study introduces a new method for discovering potent Hsp90 inhibitors by assembling fragments, providing a novel approach for finding anti-nasopharyngeal carcinoma agents. Through chemotyping analysis and click chemistry, 15 anti-Hsp90 fragments were identified, 21 compounds were synthesized, and the more potent 4f inhibitor was discovered.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Plant Sciences

Limonoids from Guarea guidonia and Cedrela odorata: Heat Shock Protein 90 (Hsp90) Modulator Properties of Chisomicine D

Maria Laura Bellone et al.

Summary: Nine new limonoids were isolated from Guarea guidonia and Cedrela odorata, including three A2,B,D-seco-type limonoids, a mexicanolide, three nomilin-type limonoids, and two limonol derivatives. Among them, chisomicine D demonstrated the highest affinity as a type of client-selective Hsp90 inhibitor through biochemical and cellular assays, and molecular docking. The study also utilized a DFT/NMR procedure to define the relative configurations of certain limonoids.

JOURNAL OF NATURAL PRODUCTS (2021)

Add to Collection

Article Multidisciplinary Sciences

Client binding shifts the populations of dynamic Hsp90 conformations through an allosteric network

Abraham Lopez et al.

Summary: Hsp90, a molecular chaperone, forms a key intermediate state induced by ATP binding, with rotations in the N-terminal domain affecting distant client sites. Client-specific interactions select and enhance the rotated state of Hsp90, promoting closing of the full-length dimer. The co-chaperone p23 shifts Hsp90 towards the closed state, enhancing client interaction and processing.

SCIENCE ADVANCES (2021)

Add to Collection

Article Chemistry, Medicinal

Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo

Yi-Min Liu et al.

Summary: Compound 6b, a designed HSP90 inhibitor, exhibits potent antiproliferative activity against various cancer cell lines, with good pharmacokinetic properties and stability. It shows potential as a lead compound for the development of lung cancer therapeutics.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Multidisciplinary Sciences

Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastoma

Trang T. T. Nguyen et al.

Summary: The inhibition of AURKA can lead to metabolic reprogramming in glioblastoma cells, enhancing mitochondrial activity, and inhibiting oxidative metabolism can sensitize the cells. Combining AURKA inhibitors with FAO inhibitors extends overall survival in GBM models.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article

Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?

Alexander J. Bridges et al.

Oncotarget (2021)

Add to Collection

Review Pharmacology & Pharmacy

The disruption of protein-protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition

Michael A. Serwetnyk et al.

Summary: Hsp90 is a crucial molecular chaperone with potential as a target for cancer therapy. In addition to known inhibitory mechanisms, alternative approaches for Hsp90 inhibition are being explored.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Redesign of protein nanocages: the way from 0D, 1D, 2D to 3D assembly

Chenyan Lv et al.

Summary: Compartmentalization is a key feature of living systems, where artificial protein nanocages are being designed and constructed with advancements to serve as crucial components and carriers in the fields of nanomaterials, electrochemistry, and drug delivery.

CHEMICAL SOCIETY REVIEWS (2021)

Add to Collection

Review Chemistry, Medicinal

Natural heat shock protein 90 inhibitors in cancer and inflammation

Thadeu E. M. M. Costa et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Synthesis of novel dual target inhibitors of PARP and HSP90 and their antitumor activities

Shanshan Lin et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2020)

Add to Collection

Article Chemistry, Medicinal

Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation

Shulei Zhu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Add to Collection

Article Materials Science, Biomaterials

Optimized HSP90 mediated fluorescent probes for cancer-specific bioimaging

Shulei Zhu et al.

JOURNAL OF MATERIALS CHEMISTRY B (2020)

Add to Collection

Article Chemistry, Medicinal

Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design

Mariarosaria Ferraro et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Review Oncology

Antibody-Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index

Steven Coats et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Genetics & Heredity

Transcriptome Sequencing Reveals the Traits of Spermatogenesis and Testicular Development in Large Yellow Croaker (Larimichthys crocea)

Shengyu Luo et al.

GENES (2019)

Add to Collection

Article Chemistry, Medicinal

Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl)benzannide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor

Takao Uno et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Article Chemistry, Medicinal

Design, synthesis, and biological evaluation of a series of resorcinol-based N-benzyl benzamide derivatives as potent Hsp90 inhibitors

Sun You Park et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Chemistry, Medicinal

Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis

Fen Jiang et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Oncology

Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models

Egor Bobrov et al.

ONCOTARGET (2017)

Add to Collection

Article Biochemistry & Molecular Biology

A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo

Lauren B. Crowe et al.

ACS CHEMICAL BIOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease

Valentina Cappello et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Oncology

HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors

David A. Proia et al.

MOLECULAR CANCER THERAPEUTICS (2015)

Add to Collection

Article Chemistry, Medicinal

Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold

Maurizio Taddei et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Add to Collection

Article Chemistry, Medicinal

Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors

Stefania Terracciano et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)

Add to Collection

Article Chemistry, Medicinal

Click chemistry to probe Hsp90: Synthesis and evaluation of a series of triazole-containing novobiocin analogues

Laura B. Peterson et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Add to Collection

Article Chemistry, Medicinal

Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design

BW Dymock et al.

JOURNAL OF MEDICINAL CHEMISTRY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.